Cargando…
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
Cancer is a heterogeneous disease and its treatment remains unsatisfactory with inconstant therapeutic responses. This variability could be related, at least in part, to different and highly personalized gut microbiota compositions. Different studies have shown an impact of microbiota on antitumor t...
Autores principales: | Lione, Lucia, Salvatori, Erika, Petrazzuolo, Adriana, Massacci, Alice, Maggio, Roberta, Confroti, Antonella, Compagnone, Mirco, Aurisicchio, Luigi, Ciliberto, Gennaro, Palombo, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993125/ https://www.ncbi.nlm.nih.gov/pubmed/33796408 http://dx.doi.org/10.1080/2162402X.2021.1898832 |
Ejemplares similares
-
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
por: Salvatori, Erika, et al.
Publicado: (2022) -
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
por: D’Alessio, Federico, et al.
Publicado: (2023) -
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
por: Aurisicchio, Luigi, et al.
Publicado: (2019) -
The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018) -
Linear DNA amplicons as a novel cancer vaccine strategy
por: Conforti, Antonella, et al.
Publicado: (2022)